+ Innovators and Investors Meet Digitally
+ Medical Cannabis Panel Highlights Opportunities and Challenges for the Emerging European Cannabis Market

The 20th Annual Biotech in Europe Forum (BEF) organized by SACHS Associates is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s pharmaceutical and biotech industries, this event will draw the attention of influencers, investors and media.

The Digital 20th Annual BEF is going to take place from the 21st-24th of September, and will feature a broad selection of company presentations, information sessions and panel discussions. The global company showcase gives investors the opportunity to connect with over 50 corporates that offer innovative solutions and/or are looking for capital and partnerships. With 700 registered attendees and over 2000 meetings, the BEF is one of the most renowned and established industry events in Europe.

Medical Cannabis in Europe – Panel Discussion

Schwarz Financial Communication has been an active participant in the event since the first days and is also one of this year’s official supporters. Together with our Toronto based partner Clearview Capital Consult, we have organized the Medical Cannabis Panel, which will be moderated by Marc Lakmaaker, Founder of Clearview. On the panel will be executives representing the cannabis value chain in Europe:

Florian HolzapfelCo-Founder, Cantourage GmbH
Jakob SonsCo-Founder, Managing Director & General Counsel, Cansativa GmbH
Nikolaas FaesSenior Research Analyst, Bryan, Garnier & Co Ltd.
Sita SchubertGeneral Secretary, European Medical Cannabis Association
Tejinder VirkPresident, Europe, Khiron Life Sciences Corp.

The panel will cover the opportunities and challenges for the European cannabis sector:

  • The panel will discuss some of the fundamental differences between the European and North American cannabis markets and how these have impacted market development.
  • The panel will also address what changes are required to overcome the barriers to accelerated growth.
  • Topics such as regulations, form factors, science, innovation, distribution and market development activities will be discussed.
  • Finally, the panel will discuss the European cannabis market as an investment proposition and how companies are navigating their own entry into this market to deliver value to shareholders.

Please visit the official website of the 20th Annual Biotech in Europe Forum for more information.